1 – 10 of 139
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2022
- Viral interference of hepatitis C and E virus replication in novel experimental co-infection systems (2022) CELLS. 11(6).
- Study of hepatitis E virus-4 infection in human liver-chimeric, immunodeficient, and immunocompetent mice (2022) FRONTIERS IN MICROBIOLOGY. 13.
- 2021
- A role for B cells to transmit hepatitis C virus infection (2021) FRONTIERS IN IMMUNOLOGY. 12.
- Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections (2021) JOURNAL OF INFECTIOUS DISEASES. 223(1). p.128-138
- 2020
- Inflammation alters the secretome and immunomodulatory properties of human skin-derived precursor cells (2020) CELLS. 9(4).
- Experimental variables that affect human hepatocyte MV transduction in liver chimeric mice (2020) MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT. 18. p.189-198
- Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice (2020) SCIENCE ADVANCES. 6(45).
- Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes (2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(3). p.1678-1688
- Robust hepatitis E virus infection and transcriptional response in human hepatocytes (2020) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 117(3). p.1731-1741
- Updates in hepatitis E virus (HEV) field : lessons learned from human liver chimeric mice (2020) REVIEWS IN MEDICAL VIROLOGY. 30(2).